Viet Reader.

Loading...

Viet Reader.

VR.

Premier Newspaper for Vietnamese Worldwide

PR Newswire

Image: 2026 IMS | IASO Bio Presented FUCASO China Real-World Data

2026 IMS | IASO Bio Presented FUCASO China Real-World Data

--- In a large China real-world study of 281 heavily pretreated, predominantly high-risk patients with relapsed/refractory plasma cell neoplasms, FUCASO achieved a 95.9% objective response rate, a 77.2% CR/sCR rate, and a 94.1% MRD negativity rate